Tremelimumab shows promise in treatment of liver cancer
Tremelimumab treatment stabilized patients with advanced hepatocellular carcinoma due to chronic hepatitis C infection for more than 12 months, according to data presented at the AACR Annual Meeting 2012, held here March ...
Apr 3, 2012